ID

30183

Beschreibung

Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00844441

Link

https://clinicaltrials.gov/show/NCT00844441

Stichworte

Versionen (1)
  1. 18.05.18 18.05.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

18. Mai 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Leukemia NCT00844441

Englisch

Eligibility Leukemia NCT00844441

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00844441
Criteria
Beschreibung

Criteria

diagnosis of one of the following:
Beschreibung

Diagnosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0011900
myelodysplastic syndromes
Beschreibung

Myelodysplastic syndrome

Datentyp

boolean

Alias
UMLS CUI [1]
C3463824
acute myeloid leukemia (aml)
Beschreibung

Leukemia, Myelocytic, Acute

Datentyp

boolean

Alias
UMLS CUI [1]
C0023467
no acute promyelocytic leukemia with t(15;17)(q22;q12), pml/rar, or other variants
Beschreibung

Exclusion Acute Promyelocytic Leukemia

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0023487
planning to undergo aml-like intensive induction chemotherapy (e.g., "7+3" or regimen with similar or higher intensity) for untreated or relapsed disease within 1 week after study entry or has started therapy within the past 72 hours
Beschreibung

Induction Chemotherapy With intensity Planned | Disease untreated | Recurrent disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3179010
UMLS CUI [1,2]
C0522510
UMLS CUI [1,3]
C1301732
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0332155
UMLS CUI [3]
C0277556
patient characteristics:
Beschreibung

Client Characteristics

Datentyp

boolean

Alias
UMLS CUI [1]
C0815172
no hypersensitivity or allergy to fluoroquinolones, triazoles, or acyclovir
Beschreibung

Absence Hypersensitivity Fluoroquinolones | Absence Hypersensitivity Triazoles | Absence Aciclovir allergy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0020517
UMLS CUI [1,3]
C0949665
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0020517
UMLS CUI [2,3]
C0040880
UMLS CUI [3,1]
C0332197
UMLS CUI [3,2]
C0571297
ecog/who/zubrod performance status 0-1*
Beschreibung

ECOG performance status | WHO performance status scale | Zubrod Performance Status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C1298650
UMLS CUI [3]
C3714786
total bilirubin ≤ 2.5 times upper limit of normal (uln) (unless elevation is thought to be due to gilbert's syndrome or hemolysis)*
Beschreibung

Serum total bilirubin measurement | Exception Etiology Gilbert Disease | Exception Etiology Hemolysis

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0015127
UMLS CUI [2,3]
C0017551
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0015127
UMLS CUI [3,3]
C0019054
ast and alt ≤ 1.5 times uln*
Beschreibung

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
serum creatinine ≤ 1.5 times uln*
Beschreibung

Creatinine measurement, serum

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
no clinical evidence of congestive heart failure*
Beschreibung

Congestive heart failure Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C0332197
no active bleeding*
Beschreibung

Hemorrhage Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019080
UMLS CUI [1,2]
C0332197
not refractory to platelet transfusions (e.g., due to hla-alloimmunization)*
Beschreibung

Absence Unresponsive to Platelet Transfusion | Etiology HLA Alloimmunisation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0205269
UMLS CUI [1,3]
C0086818
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0019721
UMLS CUI [2,3]
C0948201
no requirement for iv antimicrobial therapy*
Beschreibung

Absence Requirement Microbicides Intravenous

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C1136254
UMLS CUI [1,4]
C1522726
agrees to undergo close follow-up that includes ≥ 3 visits per week at the seattle cancer care alliance (scca)*
Beschreibung

Compliance behavior Follow-up | Visit Quantity per week

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C3274571
UMLS CUI [2,1]
C0589121
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0332174
has a confirmed reliable caregiver and transportation*
Beschreibung

Caregiver Available | Transportation Available

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0085537
UMLS CUI [1,2]
C0470187
UMLS CUI [2,1]
C2239248
UMLS CUI [2,2]
C0470187
confirmed temporary or permanent residency within a 30-minute commute from the university of washington (uw) medical center/scca*
Beschreibung

Residence Nearby Medical center

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0237096
UMLS CUI [1,2]
C1706276
UMLS CUI [1,3]
C0565990
has identified a uw/scca hematologist/oncologist who is willing to care for the patient in the outpatient clinic* note: *additional criteria for early discharge from the hospital
Beschreibung

Availability of Hematologist Patient care | Availability of Oncologist Patient care

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C0278598
UMLS CUI [1,3]
C0017313
UMLS CUI [2,1]
C0470187
UMLS CUI [2,2]
C0259990
UMLS CUI [2,3]
C0017313
prior concurrent therapy:
Beschreibung

Therapeutic procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Beschreibung

ID.21

Datentyp

boolean

Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Leukemia NCT00844441

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00844441
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Diagnosis
Item
diagnosis of one of the following:
boolean
C0011900 (UMLS CUI [1])
Myelodysplastic syndrome
Item
myelodysplastic syndromes
boolean
C3463824 (UMLS CUI [1])
Leukemia, Myelocytic, Acute
Item
acute myeloid leukemia (aml)
boolean
C0023467 (UMLS CUI [1])
Exclusion Acute Promyelocytic Leukemia
Item
no acute promyelocytic leukemia with t(15;17)(q22;q12), pml/rar, or other variants
boolean
C2828389 (UMLS CUI [1,1])
C0023487 (UMLS CUI [1,2])
Induction Chemotherapy With intensity Planned | Disease untreated | Recurrent disease
Item
planning to undergo aml-like intensive induction chemotherapy (e.g., "7+3" or regimen with similar or higher intensity) for untreated or relapsed disease within 1 week after study entry or has started therapy within the past 72 hours
boolean
C3179010 (UMLS CUI [1,1])
C0522510 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C0277556 (UMLS CUI [3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Absence Hypersensitivity Fluoroquinolones | Absence Hypersensitivity Triazoles | Absence Aciclovir allergy
Item
no hypersensitivity or allergy to fluoroquinolones, triazoles, or acyclovir
boolean
C0332197 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
C0949665 (UMLS CUI [1,3])
C0332197 (UMLS CUI [2,1])
C0020517 (UMLS CUI [2,2])
C0040880 (UMLS CUI [2,3])
C0332197 (UMLS CUI [3,1])
C0571297 (UMLS CUI [3,2])
ECOG performance status | WHO performance status scale | Zubrod Performance Status
Item
ecog/who/zubrod performance status 0-1*
boolean
C1520224 (UMLS CUI [1])
C1298650 (UMLS CUI [2])
C3714786 (UMLS CUI [3])
Serum total bilirubin measurement | Exception Etiology Gilbert Disease | Exception Etiology Hemolysis
Item
total bilirubin ≤ 2.5 times upper limit of normal (uln) (unless elevation is thought to be due to gilbert's syndrome or hemolysis)*
boolean
C1278039 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0015127 (UMLS CUI [2,2])
C0017551 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0015127 (UMLS CUI [3,2])
C0019054 (UMLS CUI [3,3])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
ast and alt ≤ 1.5 times uln*
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Creatinine measurement, serum
Item
serum creatinine ≤ 1.5 times uln*
boolean
C0201976 (UMLS CUI [1])
Congestive heart failure Absent
Item
no clinical evidence of congestive heart failure*
boolean
C0018802 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Hemorrhage Absent
Item
no active bleeding*
boolean
C0019080 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Absence Unresponsive to Platelet Transfusion | Etiology HLA Alloimmunisation
Item
not refractory to platelet transfusions (e.g., due to hla-alloimmunization)*
boolean
C0332197 (UMLS CUI [1,1])
C0205269 (UMLS CUI [1,2])
C0086818 (UMLS CUI [1,3])
C0015127 (UMLS CUI [2,1])
C0019721 (UMLS CUI [2,2])
C0948201 (UMLS CUI [2,3])
Absence Requirement Microbicides Intravenous
Item
no requirement for iv antimicrobial therapy*
boolean
C0332197 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C1136254 (UMLS CUI [1,3])
C1522726 (UMLS CUI [1,4])
Compliance behavior Follow-up | Visit Quantity per week
Item
agrees to undergo close follow-up that includes ≥ 3 visits per week at the seattle cancer care alliance (scca)*
boolean
C1321605 (UMLS CUI [1,1])
C3274571 (UMLS CUI [1,2])
C0589121 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0332174 (UMLS CUI [2,3])
Caregiver Available | Transportation Available
Item
has a confirmed reliable caregiver and transportation*
boolean
C0085537 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C2239248 (UMLS CUI [2,1])
C0470187 (UMLS CUI [2,2])
Residence Nearby Medical center
Item
confirmed temporary or permanent residency within a 30-minute commute from the university of washington (uw) medical center/scca*
boolean
C0237096 (UMLS CUI [1,1])
C1706276 (UMLS CUI [1,2])
C0565990 (UMLS CUI [1,3])
Availability of Hematologist Patient care | Availability of Oncologist Patient care
Item
has identified a uw/scca hematologist/oncologist who is willing to care for the patient in the outpatient clinic* note: *additional criteria for early discharge from the hospital
boolean
C0470187 (UMLS CUI [1,1])
C0278598 (UMLS CUI [1,2])
C0017313 (UMLS CUI [1,3])
C0470187 (UMLS CUI [2,1])
C0259990 (UMLS CUI [2,2])
C0017313 (UMLS CUI [2,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.21
Item
see disease characteristics
boolean
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video